Stocks
Omega Healthcare Investors Financial Statements (OHI) |
||||||||||
| Omega Healthcare Investorssmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 22.02.2021 | 17.02.2022 | 31.12.2022 | 14.02.2023 | 12.02.2024 | 03.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 892.4 | 1 063 | 878.2 | 878.2 | 949.7 | 965.2 | |||
| Operating Income, bln rub | 452.3 | 564.9 | 78.6 | 390.3 | 796.3 | 888.6 | ||||
| EBITDA, bln rub | ? | 782.2 | 906.9 | 995.6 | 722.7 | 829.0 | 790.1 | |||
| Net profit, bln rub | ? | 159.3 | 416.7 | 426.9 | 426.9 | 242.2 | 269.8 | |||
| OCF, bln rub | ? | 708.3 | 722.1 | 0.000 | 625.7 | 617.7 | 457.4 | |||
| CAPEX, bln rub | ? | 75.1 | 95.1 | 0.000 | 47.2 | 38.0 | 14.7 | |||
| FCF, bln rub | ? | 633.1 | 627.1 | 0.000 | 578.5 | 579.7 | 442.7 | |||
| Dividend payout, bln rub | 612.3 | 637.6 | 0.000 | 632.9 | 643.9 | 164.6 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 384.3% | 153.0% | 0.00% | 148.2% | 265.9% | 61.0% | ||||
| OPEX, bln rub | 426.4 | 482.9 | 757.7 | 469.0 | 445.7 | 160.0 | ||||
| Cost of production, bln rub | 13.8 | 13.7 | 42.0 | 17.0 | 15.0 | 30.1 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 224.3 | 234.6 | 220.3 | 233.2 | 235.5 | 223.4 | ||||
| Assets, bln rub | 9 497 | 9 638 | 8 860 | 9 405 | 9 117 | 8 361 | ||||
| Net Assets, bln rub | ? | 3 842 | 3 907 | 3 609 | 3 609 | 3 575 | 3 514 | |||
| Debt, bln rub | 5 169 | 5 254 | 19.2 | 5 287 | 5 067 | 0.000 | ||||
| Cash, bln rub | 163.5 | 20.5 | 305.6 | 297.1 | 442.8 | 361.8 | ||||
| Net debt, bln rub | 5 006 | 5 233 | -286.4 | 4 990 | 4 625 | -361.8 | ||||
| Ordinary share price, rub | 36.3 | 29.6 | 28.0 | 28.0 | 30.7 | 33.5 | ||||
| Number of ordinary shares, mln | 227.7 | 236.9 | 227.7 | 236.3 | 240.5 | 0.000 | ||||
| Market cap, bln rub | 8 272 | 7 011 | 6 365 | 6 603 | 7 374 | 0 | ||||
| EV, bln rub | ? | 13 277 | 12 244 | 6 079 | 11 593 | 11 998 | -362 | |||
| Book value, bln rub | 3 188 | 3 254 | 2 966 | 2 965 | 2 930 | 2 870 | ||||
| EPS, rub | ? | 0.70 | 1.76 | 1.87 | 1.81 | 1.01 | ||||
| FCF/share, rub | 2.78 | 2.65 | 0.00 | 2.45 | 2.41 | |||||
| BV/share, rub | 14.0 | 13.7 | 13.0 | 12.5 | 12.2 | |||||
| EBITDA margin, % | ? | 87.7% | 85.3% | 113.4% | 82.3% | 87.3% | 81.9% | |||
| Net margin, % | ? | 17.9% | 39.2% | 48.6% | 48.6% | 25.5% | 28.0% | |||
| FCF yield, % | ? | 7.65% | 8.94% | 0.00% | 8.76% | 7.86% | 0.00% | |||
| ROE, % | ? | 4.15% | 10.7% | 11.8% | 11.8% | 6.78% | 7.68% | |||
| ROA, % | ? | 1.68% | 4.32% | 4.82% | 4.54% | 2.66% | 3.23% | |||
| P/E | ? | 51.9 | 16.8 | 14.9 | 15.5 | 30.4 | 0.00 | |||
| P/FCF | 13.1 | 11.2 | 11.4 | 12.7 | 0.00 | |||||
| P/S | ? | 9.27 | 6.60 | 7.25 | 7.52 | 7.76 | 0.00 | |||
| P/BV | ? | 2.59 | 2.15 | 2.15 | 2.23 | 2.52 | 0.00 | |||
| EV/EBITDA | ? | 17.0 | 13.5 | 6.11 | 16.0 | 14.5 | -0.46 | |||
| Debt/EBITDA | 6.40 | 5.77 | -0.29 | 6.90 | 5.58 | -0.46 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| CAPEX/Revenue, % | 8.42% | 8.94% | 0.00% | 5.38% | 4.00% | 1.52% | ||||
| Omega Healthcare Investors shareholders | ||||||||||
